USF Health part of international study identifying four distinct patterns of tau spread in Alzheimer’s disease
The USF Health Byrd Alzheimer’s Center contributed to a new international study in Nature Medicine suggesting there is reason to reevaluate the concept of “typical” Alzheimer’s disease. The […]
Chaperone protein imbalance promotes toxic tau buildup in the aging brain
A USF Health study applies a new mouse model of tauopathy, which may help identify therapeutic targets for Alzheimer’s and other neurodegenerative diseases TAMPA, Fla (April 20, 2021) […]
Gopal Thinakaran appointed CEO of Byrd Alzheimer’s Center & Research Institute
Gopal Thinakaran, PhD, was recently appointed chief executive officer of the USF Health Byrd Alzheimer’s Center and Research Institute. Dr. Thinakaran assumed the position from Harry van Loveren, […]
New vaccine targeting toxic amyloid-β could help halt Alzheimer’s disease progression, preclinical study finds
University of South Florida Health neuroscientist suggests the therapeutic immunomodulatory vaccine may be safer for those with age-associated decline in immunity TAMPA, Fla (Oct. 20, 2020) — Our […]
Enzyme SSH1 impairs the disposal of accumulating cellular “garbage,” leading to brain cell death
University of South Florida Health neuroscientists discover a defect early in autophagy that may help develop SSH1 inhibitors to treat Alzheimer’s and other neurodegenerative diseases TAMPA, Fla (Oct. […]
Neuroscientist targets B-arrestins with the aim of arresting Alzheimer’s disease
The protein’s role in tau pathology is not well studied, but Alexa Woo seizes the opportunity to be first in discovering something new USF Health Alzheimer’s disease researcher […]